Partex
partex.ai
Actively hiring
Drug Discovery
Pharmaceuticals
Artificial Intelligence
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Partex is a drug discovery company that runs a network of artificial intelligence assets covering target identification, literature mining and asset valuation. Founded in 2018 in Germany, it grew out of Innoplexus and applies knowledge graphs to millions of biomedical documents. The group works with pharmaceutical partners on in-licensing and portfolio decisions.
News
Parexel, Partex Agree to Drug Discovery and Development Partnership PharmExec
Collaboration to pair artificial intelligence proficiencies with clinical research expertise.
Read more
Report
Partex And Fortress Biotech Announce Collaboration To Accelerate Biopharma Asset Evaluation
(RTTNews) - Partex NV and Fortress Biotech, Inc. (FBIO) have entered into a strategic collaboration aimed at accelerating the identification and evaluation of biopharmaceutical assets using Partex's proprietary AI-based drug discovery and development plat
Read more
Report
Parexel, Partex collaborate on leveraging AI in drug discovery and development
Parexel-Partex collab to use AI-driven solutions to accelerate drug discovery & de-risk biopharmaceutical portfolios. Combining Parexel's clinical dev. expertise & Partex's big data & AI capabilities to identify assets with highest probability of success
Read more
Report
Pro access
Upgrade to see all 6 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.